Literature DB >> 11373620

Pteridine reductase mechanism correlates pterin metabolism with drug resistance in trypanosomatid parasites.

D G Gourley1, A W Schüttelkopf, G A Leonard, J Luba, L W Hardy, S M Beverley, W N Hunter.   

Abstract

Pteridine reductase (PTR1) is a short-chain reductase (SDR) responsible for the salvage of pterins in parasitic trypanosomatids. PTR1 catalyzes the NADPH-dependent two-step reduction of oxidized pterins to the active tetrahydro-forms and reduces susceptibility to antifolates by alleviating dihydrofolate reductase (DHFR) inhibition. Crystal structures of PTR1 complexed with cofactor and 7,8-dihydrobiopterin (DHB) or methotrexate (MTX) delineate the enzyme mechanism, broad spectrum of activity and inhibition by substrate or an antifolate. PTR1 applies two distinct reductive mechanisms to substrates bound in one orientation. The first reduction uses the generic SDR mechanism, whereas the second shares similarities with the mechanism proposed for DHFR. Both DHB and MTX form extensive hydrogen bonding networks with NADP(H) but differ in the orientation of the pteridine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11373620     DOI: 10.1038/88584

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  38 in total

1.  FolM, a new chromosomally encoded dihydrofolate reductase in Escherichia coli.

Authors:  Moshe Giladi; Neta Altman-Price; Itay Levin; Liat Levy; Moshe Mevarech
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490

2.  Nonprocessive [2 + 2]e- off-loading reductase domains from mycobacterial nonribosomal peptide synthetases.

Authors:  Arush Chhabra; Asfarul S Haque; Ravi Kant Pal; Aneesh Goyal; Rajkishore Rai; Seema Joshi; Santosh Panjikar; Santosh Pasha; Rajan Sankaranarayanan; Rajesh S Gokhale
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

3.  Pterin and folate salvage. Plants and Escherichia coli lack capacity to reduce oxidized pterins.

Authors:  Alexandre Noiriel; Valeria Naponelli; Jesse F Gregory; Andrew D Hanson
Journal:  Plant Physiol       Date:  2007-01-12       Impact factor: 8.340

4.  3D-QSAR based pharmacophore modeling and virtual screening for identification of novel pteridine reductase inhibitors.

Authors:  Divya Dube; Vinita Periwal; Mukesh Kumar; Sujata Sharma; Tej P Singh; Punit Kaur
Journal:  J Mol Model       Date:  2011-08-09       Impact factor: 1.810

5.  Classification of ligand molecules in PDB with graph match-based structural superposition.

Authors:  Clara Shionyu-Mitsuyama; Atsushi Hijikata; Toshiyuki Tsuji; Tsuyoshi Shirai
Journal:  J Struct Funct Genomics       Date:  2016-12-23

6.  Acinetobacter baumannii FolD ligand complexes --potent inhibitors of folate metabolism and a re-evaluation of the structure of LY374571.

Authors:  Thomas C Eadsforth; Fernando V Maluf; William N Hunter
Journal:  FEBS J       Date:  2012-11-05       Impact factor: 5.542

7.  Predicting novel substrates for enzymes with minimal experimental effort with active learning.

Authors:  Dante A Pertusi; Matthew E Moura; James G Jeffryes; Siddhant Prabhu; Bradley Walters Biggs; Keith E J Tyo
Journal:  Metab Eng       Date:  2017-10-10       Impact factor: 9.783

8.  Trypanosoma brucei pteridine reductase 1 is essential for survival in vitro and for virulence in mice.

Authors:  Natasha Sienkiewicz; Han B Ong; Alan H Fairlamb
Journal:  Mol Microbiol       Date:  2010-06-01       Impact factor: 3.501

9.  Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.

Authors:  Lindsay B Tulloch; Viviane P Martini; Jorge Iulek; Judith K Huggan; Jeong Hwan Lee; Colin L Gibson; Terry K Smith; Colin J Suckling; William N Hunter
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

10.  One scaffold, three binding modes: novel and selective pteridine reductase 1 inhibitors derived from fragment hits discovered by virtual screening.

Authors:  Chidochangu P Mpamhanga; Daniel Spinks; Lindsay B Tulloch; Emma J Shanks; David A Robinson; Iain T Collie; Alan H Fairlamb; Paul G Wyatt; Julie A Frearson; William N Hunter; Ian H Gilbert; Ruth Brenk
Journal:  J Med Chem       Date:  2009-07-23       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.